Listen: Biogen’s new CEO, how the midterms affect science, & a biotech bankruptcy

How can Biogen right the ship? What happened to that “red wave”? And what can NASCAR teach us about public health?

STAT Washington correspondent Sarah Owermohle joins us to explain how this week’s midterm elections will affect health and medicine, and what the politicization of the pandemic means for the future of science in the U.S. We also discuss the incoming CEOs of Biogen and Seagen, plus a pair of biotech collapses.

Read the rest…